Product Usage: This product is intended for research purposes only.
All product information available on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. This product should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Brain Research Bundle
During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly same as standards.
The Brain Research Bundle pairs two synthetic peptide compounds, Semax and Selank, frequently studied together in neurological signalling pathway research. Semax is studied for its proposed interactions with specific molecular pathways relevant to neurotrophic signalling, while Selank, a heptapeptide derived from modification of the tuftsin sequence, is studied for its receptor binding properties. Research applications include comparative neuropeptide pathway studies and combined-protocol neurological signalling research.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
| Synonyms | Brain Research Bundle |
|---|---|
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
What distinguishes Semax and Selank's proposed mechanisms in neurological signalling research?
Semax (Met-Glu-His-Phe-Pro-Gly-Pro) and Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) are structurally distinct synthetic peptides studied for different proposed mechanisms: Semax for interactions with neurotrophic signalling pathways and Selank, a tuftsin-derived heptapeptide, for distinct receptor binding properties. Comparative research using both compounds allows investigators to examine whether their differing structural and mechanistic profiles produce distinguishable or overlapping effects in shared experimental models.
What experimental endpoints are used to study this peptide combination in neurological research models?
Rodent behavioral and cognitive testing paradigms, alongside molecular markers of neurotrophic signalling (such as BDNF expression) and receptor pathway activation, are standard endpoints for studying this combination's proposed neurological effects, typically compared across single-compound and combined-compound treatment arms relative to vehicle controls.
How is the proteolytic stability of Semax and Selank addressed in experimental protocol design?
Both Semax and Selank are short synthetic peptides studied with attention to proteolytic stability in experimental design, since peptide degradation can affect the consistency of dosing and timing in research protocols. Researchers typically account for this through standardized handling, storage, and administration timing documented in their experimental methods.
